Induction of Anti-Tumor Immunity with Epidermal Cells Pulsed with Tumor-Derived RNA or Intradermal Administration of RNA
Open Access
- 1 April 2000
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 114 (4), 632-636
- https://doi.org/10.1046/j.1523-1747.2000.00929.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNANature Biotechnology, 1998
- Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System TumorsThe Journal of Experimental Medicine, 1997
- Regulation of tumor antigen presentation by urocanic acid.The Journal of Immunology, 1997
- Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.The Journal of Experimental Medicine, 1996
- Dermal Dendritic Cells are Important Members of the Skin Immune SystemAdvances in experimental medicine and biology, 1995
- Interleukin 1α but Not Transforming Growth Factor β Inhibits Tumor Antigen Presentation by Epidermal Antigen-Presenting CellsJournal of Investigative Dermatology, 1994
- Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.The Journal of Experimental Medicine, 1989
- Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.The Journal of Experimental Medicine, 1987
- Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes.The Journal of Experimental Medicine, 1986
- Immunosuppressor T Cells in Tumor Bearing HostsImmunological Communications, 1975